Brelovitug 900 mg clinical trials

A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection

This study is looking at a new medicine called Brelovitug (BJT-778) for chronic Hepatitis Delta. It compares different doses of the medicine and also looks at starting treatment now versus starting it later to see how well it works and if it's safe.